CGCN GROUP, LLC for FRESENIUS KABI USA, LLC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Manufacturing MAN
Sec. 232 investigation on pharmaceutical sector, tariffs, Buy America policies, Most Favored Nations Executive Order, reciprocal tariffs, essential medicines drug shortages related to trade agreements. U.S. manufacturing incentives. Buy America legislation, tariffs, tax incentives, regulatory barriers to generic and biosimilar launches, patent waivers. Section 232 investigation into pharmaceuticals and unfair trade practices.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL HAMAKER New | — |
| MARTHA BEATRICE MILLER New | Confidential Assistant, U.S. Department of Education, 2017-2019; Deputy Director of Scheduling, Sen. Ted Cruz (TX), 2019-2020; Scheduler, Rep. Warren Davidson (OH-08), 2020-2022. |
Tariff (miscellaneous tariff bills) TAR
Sec. 232 investigation on pharmaceutical sector, tariffs, Buy America policies, Most Favored Nations Executive Order, reciprocal tariffs, essential medicines drug shortages related to trade agreements. U.S. manufacturing incentives. Buy America legislation, tariffs, tax incentives, regulatory barriers to generic and biosimilar launches, patent waivers. Section 232 investigation into pharmaceuticals and unfair trade practices.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL HAMAKER New | — |
| MARTHA BEATRICE MILLER New | Confidential Assistant, U.S. Department of Education, 2017-2019; Deputy Director of Scheduling, Sen. Ted Cruz (TX), 2019-2020; Scheduler, Rep. Warren Davidson (OH-08), 2020-2022. |
Taxation/Internal Revenue Code TAX
Sec. 232 investigation on pharmaceutical sector, tariffs, Buy America policies, Most Favored Nations Executive Order, reciprocal tariffs, essential medicines drug shortages related to trade agreements. U.S. manufacturing incentives. Buy America legislation, tariffs, tax incentives, regulatory barriers to generic and biosimilar launches, patent waivers. Section 232 investigation into pharmaceuticals and unfair trade practices.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL HAMAKER New | — |
| MARTHA BEATRICE MILLER New | Confidential Assistant, U.S. Department of Education, 2017-2019; Deputy Director of Scheduling, Sen. Ted Cruz (TX), 2019-2020; Scheduler, Rep. Warren Davidson (OH-08), 2020-2022. |
Trade (domestic/foreign) TRD
Sec. 232 investigation on pharmaceutical sector, tariffs, Buy America policies, Most Favored Nations Executive Order, reciprocal tariffs, essential medicines drug shortages related to trade agreements. U.S. manufacturing incentives. Buy America legislation, tariffs, tax incentives, regulatory barriers to generic and biosimilar launches, patent waivers. Section 232 investigation into pharmaceuticals and unfair trade practices.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JILL HAMAKER New | — |
| MARTHA BEATRICE MILLER New | Confidential Assistant, U.S. Department of Education, 2017-2019; Deputy Director of Scheduling, Sen. Ted Cruz (TX), 2019-2020; Scheduler, Rep. Warren Davidson (OH-08), 2020-2022. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.